Methylphenidate Hydrochloride 00527-3313
Product NDC
00527-3313- Manufacturer
- Lannett Company, Inc.
- Dosage Form
- Tablet, Extended Release
- Route
- Oral
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CII
- Marketing Start
- April 24, 2019
- Listing Expires
- December 31, 2027
- Application
- ANDA211918
Active Ingredients
| Ingredient | Strength |
|---|---|
| Methylphenidate Hydrochloride | 54 mg/1 |
Drug Class
Central Nervous System Stimulant [EPC]Central Nervous System Stimulation [PE]
Packaging Options(1)
100 TABLET, EXTENDED RELEASE in 1 BOTTLE (0527-3313-37)